BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 37669090)

  • 1. Integrative multiomics-histopathology analysis for breast cancer classification.
    Ektefaie Y; Yuan W; Dillon DA; Lin NU; Golden JA; Kohane IS; Yu KH
    NPJ Breast Cancer; 2021 Nov; 7(1):147. PubMed ID: 34845230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic pan-cancer study on deep learning-based prediction of multi-omic biomarkers from routine pathology images.
    Arslan S; Schmidt J; Bass C; Mehrotra D; Geraldes A; Singhal S; Hense J; Li X; Raharja-Liu P; Maiques O; Kather JN; Pandya P
    Commun Med (Lond); 2024 Mar; 4(1):48. PubMed ID: 38491101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HER2 from Haematoxylin-Eosin Slides Through a Cascade of Deep Learning Classifiers via Multi-Instance Learning.
    La Barbera D; Polónia A; Roitero K; Conde-Sousa E; Della Mea V
    J Imaging; 2020 Aug; 6(9):. PubMed ID: 34460739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weakly Supervised AI for Efficient Analysis of 3D Pathology Samples.
    Song AH; Williams M; Williamson DFK; Jaume G; Zhang A; Chen B; Serafin R; Liu JTC; Baras A; Parwani AV; Mahmood F
    ArXiv; 2023 Jul; ():. PubMed ID: 37547660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic bias in misdiagnosis by computational pathology models.
    Vaidya A; Chen RJ; Williamson DFK; Song AH; Jaume G; Yang Y; Hartvigsen T; Dyer EC; Lu MY; Lipkova J; Shaban M; Chen TY; Mahmood F
    Nat Med; 2024 Apr; 30(4):1174-1190. PubMed ID: 38641744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classifying breast cancer and fibroadenoma tissue biopsies from paraffined stain-free slides by fractal biomarkers in Fourier Ptychographic Microscopy.
    Bianco V; Valentino M; Pirone D; Miccio L; Memmolo P; Brancato V; Coppola L; Smaldone G; D'Aiuto M; Mossetti G; Salvatore M; Ferraro P
    Comput Struct Biotechnol J; 2024 Dec; 24():225-236. PubMed ID: 38572166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression-based Deep-Learning predicts molecular biomarkers from pathology slides.
    El Nahhas OSM; Loeffler CML; Carrero ZI; van Treeck M; Kolbinger FR; Hewitt KJ; Muti HS; Graziani M; Zeng Q; Calderaro J; Ortiz-Brüchle N; Yuan T; Hoffmeister M; Brenner H; Brobeil A; Reis-Filho JS; Kather JN
    Nat Commun; 2024 Feb; 15(1):1253. PubMed ID: 38341402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing role of pathology in breast cancer diagnosis and treatment.
    Leong AS; Zhuang Z
    Pathobiology; 2011; 78(2):99-114. PubMed ID: 21677473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology of Luminal Breast Cancer.
    Erber R; Hartmann A
    Breast Care (Basel); 2020 Aug; 15(4):327-336. PubMed ID: 32982642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-Efficient Computational Pathology Platform for Faster and Cheaper Breast Cancer Subtype Identifications: Development of a Deep Learning Model.
    Bae K; Jeon YS; Hwangbo Y; Yoo CW; Han N; Feng M
    JMIR Cancer; 2023 Sep; 9():e45547. PubMed ID: 37669090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
    Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
    Front Oncol; 2021; 11():706733. PubMed ID: 34490107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining breast cancer biomarker status and associated morphological features using deep learning.
    Gamble P; Jaroensri R; Wang H; Tan F; Moran M; Brown T; Flament-Auvigne I; Rakha EA; Toss M; Dabbs DJ; Regitnig P; Olson N; Wren JH; Robinson C; Corrado GS; Peng LH; Liu Y; Mermel CH; Steiner DF; Chen PC
    Commun Med (Lond); 2021; 1():14. PubMed ID: 35602213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast Cancer.
    Xing D; Lv Y; Sun B; Chu T; Bao Q; Zhang H
    Acad Radiol; 2024 Apr; ():. PubMed ID: 38641451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Molecular Subtyping of Breast Carcinoma Using Deep Learning Techniques.
    Niyas S; Bygari R; Naik R; Viswanath B; Ugwekar D; Mathew T; Kavya J; Kini JR; Rajan J
    IEEE J Transl Eng Health Med; 2023; 11():161-169. PubMed ID: 36816095
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.